JP2019524679A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019524679A5 JP2019524679A5 JP2018568424A JP2018568424A JP2019524679A5 JP 2019524679 A5 JP2019524679 A5 JP 2019524679A5 JP 2018568424 A JP2018568424 A JP 2018568424A JP 2018568424 A JP2018568424 A JP 2018568424A JP 2019524679 A5 JP2019524679 A5 JP 2019524679A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- volume
- weight
- salbutamol
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TNTN2016/0259 | 2016-06-27 | ||
| TN2016000259A TN2016000259A1 (en) | 2016-06-27 | 2016-06-27 | Salbutamol (albuterol) eye protective medicament. |
| PCT/IB2017/000779 WO2018007864A1 (en) | 2016-06-27 | 2017-06-27 | Salbutamol-containing ophthalmic medicament |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019524679A JP2019524679A (ja) | 2019-09-05 |
| JP2019524679A5 true JP2019524679A5 (enExample) | 2020-02-27 |
| JP7176960B2 JP7176960B2 (ja) | 2022-11-22 |
Family
ID=59416735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018568424A Expired - Fee Related JP7176960B2 (ja) | 2016-06-27 | 2017-06-27 | サルブタモール含有眼科用医薬 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11484513B2 (enExample) |
| EP (1) | EP3474836B1 (enExample) |
| JP (1) | JP7176960B2 (enExample) |
| CN (1) | CN110114066B (enExample) |
| MA (1) | MA45457A (enExample) |
| TN (1) | TN2016000259A1 (enExample) |
| WO (1) | WO2018007864A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119097618A (zh) * | 2019-03-02 | 2024-12-10 | 内在生物技术有限公司 | 用于治疗疾病的亮氨酸、乙酰基亮氨酸和相关类似物 |
| KR20220018484A (ko) * | 2019-06-10 | 2022-02-15 | 제니비젼 인크. | 시력 장애를 치료하기 위한 방법 및 제형 |
| MD3989962T2 (ro) | 2019-06-28 | 2025-12-31 | Intrabio Ltd Gb | Terapie combinată cu acetil-leucină și miglustat pentru tratamentul unei boli de depozitare lizozomală |
| JP7066293B2 (ja) * | 2019-11-12 | 2022-05-13 | 株式会社ファンケル | サーチュイン１（ｓｉｒｔ１）発現増強用組成物 |
| WO2021144720A1 (en) | 2020-01-13 | 2021-07-22 | Intrabio Ltd | Treatment of late-onset neurodegenerative diseases in heterozygous npc1 gene mutation carriers |
| KR20230015433A (ko) * | 2020-05-22 | 2023-01-31 | 인트라바이오 리미티드 | 운동실조를 치료하기 위한 아세틸 류신과 4-아미노피리딘 또는 아세타졸아미드의 조합물 |
| EP4694929A1 (en) * | 2023-04-08 | 2026-02-18 | Sung-Jan Lin | Methods for treating corneal injuries |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3985897A (en) * | 1973-12-21 | 1976-10-12 | Mead Johnson & Company | Ocular hypotensive process employing dextrorotatory sulfonamidophenethanolamines |
| SE8701258D0 (sv) * | 1987-03-26 | 1987-03-26 | Pharmacia Ab | A composition for the topical treatment of glaucoma or ocular hypertension |
| US5192780A (en) * | 1989-12-18 | 1993-03-09 | Alcon Laboratories, Inc. | Methods using antiallergics and antihistamines |
| US6569903B2 (en) * | 1999-12-07 | 2003-05-27 | Rohto Pharmaceutical Co., Ltd. | Ophthalmic compositions |
| WO2003049745A1 (en) | 2001-12-12 | 2003-06-19 | Pharmacia Corporation | Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| EP2311793A1 (en) | 2004-12-17 | 2011-04-20 | Cipla Ltd. | Crystalline levosalbutamol sulphate (Form II) |
| WO2010125416A1 (en) | 2009-04-27 | 2010-11-04 | Raouf Rekik | Drug delivery to the anterior and posterior segments of the eye |
| WO2011068786A2 (en) * | 2009-12-02 | 2011-06-09 | Bridge Pharma, Inc. | Treating xerophthalmia with compounds increasing meibomian gland secretion |
| TN2010000251A1 (fr) | 2010-06-03 | 2011-11-11 | Rekik Raouf | N-acetyl-dl-leucine medicament neuro et retino protecteur |
| TN2010000566A1 (en) | 2010-12-03 | 2012-05-24 | Rekik Raouf | Folic acid - ramipril combination : cell protective neuroprotective and retinoprotective ophtalmologic drugs |
| WO2014191414A1 (en) * | 2013-05-28 | 2014-12-04 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Syrup formulation of salbutamol |
-
2016
- 2016-06-27 TN TN2016000259A patent/TN2016000259A1/en unknown
-
2017
- 2017-06-27 WO PCT/IB2017/000779 patent/WO2018007864A1/en not_active Ceased
- 2017-06-27 MA MA045457A patent/MA45457A/fr unknown
- 2017-06-27 JP JP2018568424A patent/JP7176960B2/ja not_active Expired - Fee Related
- 2017-06-27 EP EP17745488.1A patent/EP3474836B1/en active Active
- 2017-06-27 CN CN201780052188.6A patent/CN110114066B/zh active Active
- 2017-06-27 US US16/313,425 patent/US11484513B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7116490B2 (ja) | 眼の炎症性障害および疾患の組合せ処置 | |
| L Lindstrom et al. | Dropless cataract surgery: an overview | |
| Al Dhibi et al. | Clinical trials on corticosteroids for diabetic macular edema | |
| JP5897592B2 (ja) | 葉酸−ラミプリルの組合せ：細胞保護性、神経保護性、および網膜保護性の眼科用組成物 | |
| CN104185472B (zh) | 4‑孕甾烯‑11β‑17‑21‑三醇‑3，20‑二酮衍生物的药物组合物和使用方法 | |
| WO2023177689A1 (en) | Extended, high dose vegf antagonist regimens for treatment of angiogenic eye disorders | |
| EP3359257B1 (en) | Use of medications with neuroprotective properties to prevent or reduce the risk of ischemia-reperfusion injury in a subject | |
| Abadia et al. | Clinical applications of dexamethasone for aged eyes | |
| CN110114066B (zh) | 含沙丁胺醇的眼科药物 | |
| WO2020255135A1 (en) | Treatment of ocular inflammatory diseases with topical ophthalmic tapinarof compositions | |
| Grzybowski et al. | Dexamethasone intraocular suspension: a long-acting therapeutic for treating inflammation associated with cataract surgery | |
| Carreño et al. | Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction | |
| Kandasamy et al. | New treatment modalities for geographic atrophy | |
| HERMAN | Endogenous uveitis: Current concepts of treatment | |
| US20250025531A1 (en) | Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye Disorders | |
| Cho et al. | New look at ocular inflammation control–powerful and fast-acting twice-daily bromfenac for a novel standard in the treatment of inflammation | |
| Levison | Noninfectious Uveitis: Systemic and Local Corticosteroids | |
| HK40099475A (en) | Extended, high dose vegf antagonist regimens for treatment of angiogenic eye disorders | |
| WO2026010946A1 (en) | Zifibancimig for use in methods for treating ocular diseases via an ocular implant | |
| Mavrikakis et al. | Current trends of intravitreal steroid use in retinal diseases | |
| Croasdell | Association for Research in Vision and Ophthalmology (ARVO)-2016 Annual Meeting. Seattle, Washington, USA-April 29-May 5, 2016 | |
| Francis et al. | Topical Therapy in Uveitis | |
| Pichi et al. | Drugs used in ocular treatment | |
| Escott et al. | Medical Management of CME Associated with Uveitis | |
| Hennessy et al. | Anecortave acetate: a new approach for the medical treatment of glaucoma |